• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于紫色产色小单孢菌NRRL B-16094生产庆大霉素的D-最优设计模型和生物合成途径

D-optimal design model and biosynthetic pathway for gentamicin production by Micromonospora purpureochromogenes NRRL B-16094.

作者信息

Suliman Muath, Bishr Amr S, Tohamy Sally T K, Alshahrani Mohammad Y, Aboshanab Khaled M

机构信息

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha 9088, P.O. Box 61413, Saudi Arabia.

Department of Microbiology and Immunology, Faculty of Pharmacy , Ain Shams University, Cairo, 11566, Egypt.

出版信息

BMC Microbiol. 2025 May 20;25(1):309. doi: 10.1186/s12866-025-04001-8.

DOI:10.1186/s12866-025-04001-8
PMID:40394500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12090562/
Abstract

BACKGROUND

Micromonospora purpureochromogenes NRRL B-16094, a natural producer of gentamicin (GEN), a 5,6-diglycosylated 2-dexoystreptamine-aminoglycoside antibiotic (2DOS-AGA) broad-spectrum bactericidal activity. In literature, limited studies are concerned with the biosynthetic route and various cultural conditions influencing GEN production.

METHODS

Therefore, this study aimed to explore the GEN biosynthesis pathway and compare it to that of fortimicin and kanamycin. In addition, four key environmental conditions influencing GEN production were statistically optimized using response surface D-optimal design (DOD). Herein, the biosynthetic pathway of GEN was proposed based on the biochemistry of the identified genes/proteins within the gene cluster. Comparing the GEN-biosynthetic gene cluster to that of kanamycin and fortimicin suggested that gentamicin biosynthesis could have originated from a combination of biosynthetic pathways of both antibiotics.

RESULTS

For the optimization experiments, culture media 4 (CM4) and 6 (CM6) gave the highest specific productivity at 6.36 and 3.80 µg/mg, respectively. A DOD quadratic model was successfully generated to optimize four key environmental factors. Predicted and experimentally confirmed optimized factors were an initial pH of 7, an incubation temperature of 30˚C, and an agitation of 300 rpm for 10 days. This resulted in a 13.5-fold increase (289.5 µg/mL) over that produced by the basic CM1 production medium (21.4 µg/mL) and 2.4 times (over that obtained by CM4 (123.7 µg/mL) as verified by HPLC analysis.

CONCLUSION

DOD is an efficient tool for optimizing GEN. Accordingly, the optimized conditions are highly advisable during the scaling up of GEN production by M. purpureochromogenes NRRL B-16094.

摘要

背景

紫色产色小单孢菌NRRL B - 16094是庆大霉素(GEN)的天然生产者,庆大霉素是一种具有5,6 - 二糖基化的2 - 脱氧链霉胺 - 氨基糖苷抗生素(2DOS - AGA),具有广谱杀菌活性。在文献中,关于庆大霉素生物合成途径以及影响其产生的各种培养条件的研究有限。

方法

因此,本研究旨在探索庆大霉素的生物合成途径,并将其与福提霉素和卡那霉素的生物合成途径进行比较。此外,使用响应面D - 最优设计(DOD)对影响庆大霉素产生的四个关键环境条件进行了统计优化。在此,基于基因簇中已鉴定基因/蛋白质的生物化学提出了庆大霉素的生物合成途径。将庆大霉素生物合成基因簇与卡那霉素和福提霉素的基因簇进行比较表明,庆大霉素的生物合成可能起源于这两种抗生素生物合成途径的组合。

结果

对于优化实验,培养基4(CM4)和6(CM6)的比生产率最高,分别为6.36和3.80μg/mg。成功生成了一个DOD二次模型以优化四个关键环境因素。预测并经实验证实的优化因素为初始pH值7、培养温度30˚C以及搅拌速度300 rpm,培养10天。这导致产量比基本的CM1生产培养基(21.4μg/mL)提高了13.5倍(289.5μg/mL),并且经高效液相色谱分析验证,比CM4(123.7μg/mL)提高了2.4倍。

结论

DOD是优化庆大霉素的有效工具。因此,在紫色产色小单孢菌NRRL B - 16094扩大生产庆大霉素的过程中,高度建议采用优化条件。

相似文献

1
D-optimal design model and biosynthetic pathway for gentamicin production by Micromonospora purpureochromogenes NRRL B-16094.用于紫色产色小单孢菌NRRL B-16094生产庆大霉素的D-最优设计模型和生物合成途径
BMC Microbiol. 2025 May 20;25(1):309. doi: 10.1186/s12866-025-04001-8.
2
Deciphering hygromycin B biosynthetic pathway and D-optimal design for production optimization.解读潮霉素B生物合成途径及用于产量优化的D-最优设计。
World J Microbiol Biotechnol. 2025 Apr 28;41(5):155. doi: 10.1007/s11274-025-04364-0.
3
Response Surface D-Optimal Design for Optimizing Fortimicins Production by Micromonospora olivasterospora and New Synergistic Fortimicin-A-Antibiotic Combinations.用于优化橄榄小单孢菌生产福提霉素的响应面D-最优设计及新型福提霉素A-抗生素协同组合
Curr Microbiol. 2025 Jan 3;82(2):68. doi: 10.1007/s00284-024-04049-1.
4
Characterization of a key aminoglycoside phosphotransferase in gentamicin biosynthesis.庆大霉素生物合成中关键氨基糖苷磷酸转移酶的特性研究。
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1438-41. doi: 10.1016/j.bmcl.2012.12.064. Epub 2013 Jan 3.
5
Assembly of a novel biosynthetic pathway for gentamicin B production in Micromonospora echinospora.在棘孢小单孢菌中构建用于生产庆大霉素B的新型生物合成途径。
Microb Cell Fact. 2016 Jan 5;15:1. doi: 10.1186/s12934-015-0402-6.
6
Methylation of 16S ribosomal RNA and resistance to the aminoglycoside antibiotics gentamicin and kanamycin determined by DNA from the gentamicin-producer, Micromonospora purpurea.由庆大霉素产生菌紫色小单孢菌的DNA所确定的16S核糖体RNA甲基化以及对氨基糖苷类抗生素庆大霉素和卡那霉素的抗性。
Mol Gen Genet. 1985;201(2):168-73. doi: 10.1007/BF00425655.
7
Molecular cloning and characterization of a 2-deoxystreptamine biosynthetic gene cluster in gentamicin-producing Micromonospora echinospora ATCC15835.庆大霉素产生菌棘孢小单孢菌ATCC15835中2-脱氧链霉胺生物合成基因簇的分子克隆与特性分析
Mol Cells. 2004 Aug 31;18(1):71-8.
8
Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set.通过庆大霉素A2最小基因集的异源表达对其生物合成途径进行遗传剖析。
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8399-404. doi: 10.1073/pnas.0803164105. Epub 2008 Jun 12.
9
In Vivo Characterization of Phosphotransferase-Encoding Genes istP and forP as Interchangeable Launchers of the C3',4'-Dideoxygenation Biosynthetic Pathway of 1,4-Diaminocyclitol Antibiotics.磷酸转移酶编码基因istP和forP作为1,4-二氨基环醇抗生素C3',4'-双脱氧生物合成途径可互换启动子的体内表征
J Microbiol Biotechnol. 2019 Mar 28;29(3):367-372. doi: 10.4014/jmb.1809.09021.
10
Biosynthetic pathway leading to gentamicin C2b.通往庆大霉素C2b的生物合成途径。
Antimicrob Agents Chemother. 1979 Nov;16(5):589-91. doi: 10.1128/AAC.16.5.589.

本文引用的文献

1
Response Surface D-Optimal Design for Optimizing Fortimicins Production by Micromonospora olivasterospora and New Synergistic Fortimicin-A-Antibiotic Combinations.用于优化橄榄小单孢菌生产福提霉素的响应面D-最优设计及新型福提霉素A-抗生素协同组合
Curr Microbiol. 2025 Jan 3;82(2):68. doi: 10.1007/s00284-024-04049-1.
2
Combinatorial biosynthesis of novel aminoglycoside antibiotics via pathway engineering.通过途径工程进行新型氨基糖苷类抗生素的组合生物合成。
AMB Express. 2024 Sep 16;14(1):103. doi: 10.1186/s13568-024-01753-w.
3
Central composite design for optimizing istamycin production by Streptomyces tenjimariensis.
用中心复合设计优化棘孢小单孢菌产生棘霉素。
World J Microbiol Biotechnol. 2024 Sep 9;40(10):316. doi: 10.1007/s11274-024-04118-4.
4
Scale-Up of the Fermentation Process for the Production and Purification of Serratiopeptidase Using Silkworm Pupae as a Substrate.以蚕蛹为底物扩大用于生产和纯化沙雷氏菌蛋白酶的发酵工艺规模。
Methods Protoc. 2024 Feb 25;7(2):19. doi: 10.3390/mps7020019.
5
Application of I-Optimal Design for Modeling and Optimizing the Operational Parameters of Ibuprofen Granules in Continuous Twin-Screw Wet Granulation.I-最优设计在布洛芬颗粒连续双螺杆湿法制粒操作参数建模与优化中的应用
Biomedicines. 2023 Jul 19;11(7):2030. doi: 10.3390/biomedicines11072030.
6
Production of Bacillus subtilis soil isolate as biocontrol agent under bioreactor conditions.在生物反应器条件下生产枯草芽孢杆菌土壤分离株作为生物防治剂。
Arch Microbiol. 2023 Jan 4;205(1):52. doi: 10.1007/s00203-022-03381-z.
7
Amphiphilic aminoglycosides: Modifications that revive old natural product antibiotics.两亲性氨基糖苷类:使古老的天然产物抗生素重焕生机的修饰。
Front Microbiol. 2022 Sep 23;13:1000199. doi: 10.3389/fmicb.2022.1000199. eCollection 2022.
8
D-optimal design of the additive mixture model with multi-response.多响应添加剂混合模型的 D-最优设计。
Math Biosci Eng. 2022 Mar 10;19(5):4737-4748. doi: 10.3934/mbe.2022221.
9
Octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate, an antifungal metabolite of Alcaligenes faecalis strain MT332429 optimized through response surface methodology.十八烷基 3-(3,5-二叔丁基-4-羟基苯基)丙酸盐,一种通过响应面法优化的粪产碱杆菌 MT332429 的抗真菌代谢产物。
Appl Microbiol Biotechnol. 2020 Dec;104(24):10755-10768. doi: 10.1007/s00253-020-10962-9. Epub 2020 Oct 22.
10
Aminoglycoside Resistance: Updates with a Focus on Acquired 16S Ribosomal RNA Methyltransferases.氨基糖苷类抗生素耐药性:以获得性 16S 核糖体 RNA 甲基转移酶为重点的更新。
Infect Dis Clin North Am. 2020 Dec;34(4):887-902. doi: 10.1016/j.idc.2020.06.002. Epub 2020 Sep 30.